Close



Apr 16, 2024 09:11AM
Apr 16, 2024 09:10AM
Apr 16, 2024 08:10AM
Apr 2, 2024 09:01AM
Apr 2, 2024 09:00AM
Apr 2, 2024 08:00AM
Mar 14, 2024 09:20AM Lexaria Appoints Nelson Cabatuan as Chief Financial Officer
Mar 14, 2024 09:11AM
Mar 14, 2024 08:10AM
Mar 7, 2024 09:06AM
Mar 7, 2024 09:05AM
Mar 7, 2024 08:05AM
Mar 5, 2024 09:05AM
Mar 5, 2024 05:05AM Lexaria to Begin Diabetes and Weight Loss Animal Study WEIGHT-A24-1
Mar 4, 2024 08:15AM
Mar 4, 2024 08:15AM
Mar 1, 2024 08:21AM
Mar 1, 2024 08:20AM
Mar 1, 2024 07:20AM
Feb 16, 2024 06:00PM
Feb 16, 2024 04:05PM Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Feb 15, 2024 08:02AM
Feb 15, 2024 08:00AM
Jan 30, 2024 08:48AM
Jan 30, 2024 08:45AM
Jan 24, 2024 08:48AM
Jan 24, 2024 08:45AM
Jan 16, 2024 09:13AM Lexaria Bioscience (LEXX) Unveils Planned 2024 GLP-1 Study Program
Jan 16, 2024 09:10AM
Jan 4, 2024 09:07AM
Jan 4, 2024 09:05AM
Dec 7, 2023 09:22AM
Dec 7, 2023 09:20AM
Nov 28, 2023 09:10AM
Oct 13, 2023 09:07AM Lexaria (LEXX) Enters New Global Exclusive Collaboration and License Agreement with SulfoSyn
Oct 13, 2023 09:05AM
Oct 12, 2023 09:13AM
Oct 12, 2023 09:10AM
Sep 29, 2023 08:01AM
Sep 29, 2023 08:00AM
Sep 21, 2023 09:10AM
Aug 30, 2023 09:26AM Lexaria Bioscience (LEXX) Provides Update on Investigational New Drug Application Progress
Aug 30, 2023 09:20AM
Aug 9, 2023 09:15AM
Aug 2, 2023 09:13AM
Jul 28, 2023 09:10AM
Jul 19, 2023 09:07AM
Jul 19, 2023 09:05AM
Jun 22, 2023 09:26AM Lexaria Bioscience (LEXX) Reports Publication of Research into DehydraTECH-CBD
Jun 22, 2023 09:25AM

251,775 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All